PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells

Abstract Cancer cells experience endoplasmic reticulum (ER) stress due to activated oncogenes and conditions of nutrient deprivation and hypoxia. The ensuing unfolded protein response (UPR) is executed by ATF6, IRE1 and PERK pathways. Adaptation to mild ER stress promotes tumor cell survival and agg...

Full description

Bibliographic Details
Main Authors: Namratha Sheshadri, Dipak K. Poria, Shikha Sharan, Ying Hu, Chunhua Yan, Vishal N. Koparde, Kuppusamy Balamurugan, Esta Sterneck
Format: Article
Language:English
Published: Nature Publishing Group 2021-11-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-021-04318-y
_version_ 1830285242409156608
author Namratha Sheshadri
Dipak K. Poria
Shikha Sharan
Ying Hu
Chunhua Yan
Vishal N. Koparde
Kuppusamy Balamurugan
Esta Sterneck
author_facet Namratha Sheshadri
Dipak K. Poria
Shikha Sharan
Ying Hu
Chunhua Yan
Vishal N. Koparde
Kuppusamy Balamurugan
Esta Sterneck
author_sort Namratha Sheshadri
collection DOAJ
description Abstract Cancer cells experience endoplasmic reticulum (ER) stress due to activated oncogenes and conditions of nutrient deprivation and hypoxia. The ensuing unfolded protein response (UPR) is executed by ATF6, IRE1 and PERK pathways. Adaptation to mild ER stress promotes tumor cell survival and aggressiveness. Unmitigated ER stress, however, will result in cell death and is a potential avenue for cancer therapies. Because of this yin-yang nature of ER stress, it is imperative that we fully understand the mechanisms and dynamics of the UPR and its contribution to the complexity of tumor biology. The PERK pathway inhibits global protein synthesis while allowing translation of specific mRNAs, such as the ATF4 transcription factor. Using thapsigargin and tunicamycin to induce acute ER stress, we identified the transcription factor C/EBPδ (CEBPD) as a mediator of PERK signaling to secretion of tumor promoting chemokines. In melanoma and breast cancer cell lines, PERK mediated early induction of C/EBPδ through ATF4-independent pathways that involved at least in part Janus kinases and the STAT3 transcription factor. Transcriptional profiling revealed that C/EBPδ contributed to 20% of thapsigargin response genes including chaperones, components of ER-associated degradation, and apoptosis inhibitors. In addition, C/EBPδ supported the expression of the chemokines CXCL8 (IL-8) and CCL20, which are known for their tumor promoting and immunosuppressive properties. With a paradigm of short-term exposure to thapsigargin, which was sufficient to trigger prolonged activation of the UPR in cancer cells, we found that conditioned media from such cells induced cytokine expression in myeloid cells. In addition, activation of the CXCL8 receptor CXCR1 during thapsigargin exposure supported subsequent sphere formation by cancer cells. Taken together, these investigations elucidated a novel mechanism of ER stress-induced transmissible signals in tumor cells that may be particularly relevant in the context of pharmacological interventions.
first_indexed 2024-12-19T03:35:45Z
format Article
id doaj.art-c88cd23c0636472a90c4d08c51983d7f
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-12-19T03:35:45Z
publishDate 2021-11-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-c88cd23c0636472a90c4d08c51983d7f2022-12-21T20:37:24ZengNature Publishing GroupCell Death and Disease2041-48892021-11-01121111410.1038/s41419-021-04318-yPERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cellsNamratha Sheshadri0Dipak K. Poria1Shikha Sharan2Ying Hu3Chunhua Yan4Vishal N. Koparde5Kuppusamy Balamurugan6Esta Sterneck7Laboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer InstituteLaboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer InstituteLaboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer InstituteCenter for Biomedical Informatics and Information Technology, Center for Cancer Research, National Cancer InstituteCenter for Biomedical Informatics and Information Technology, Center for Cancer Research, National Cancer InstituteCCR Collaborative Bioinformatics Resource (CCBR), Center for Cancer Research, National Cancer InstituteLaboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer InstituteLaboratory of Cell and Developmental Signaling, Center for Cancer Research, National Cancer InstituteAbstract Cancer cells experience endoplasmic reticulum (ER) stress due to activated oncogenes and conditions of nutrient deprivation and hypoxia. The ensuing unfolded protein response (UPR) is executed by ATF6, IRE1 and PERK pathways. Adaptation to mild ER stress promotes tumor cell survival and aggressiveness. Unmitigated ER stress, however, will result in cell death and is a potential avenue for cancer therapies. Because of this yin-yang nature of ER stress, it is imperative that we fully understand the mechanisms and dynamics of the UPR and its contribution to the complexity of tumor biology. The PERK pathway inhibits global protein synthesis while allowing translation of specific mRNAs, such as the ATF4 transcription factor. Using thapsigargin and tunicamycin to induce acute ER stress, we identified the transcription factor C/EBPδ (CEBPD) as a mediator of PERK signaling to secretion of tumor promoting chemokines. In melanoma and breast cancer cell lines, PERK mediated early induction of C/EBPδ through ATF4-independent pathways that involved at least in part Janus kinases and the STAT3 transcription factor. Transcriptional profiling revealed that C/EBPδ contributed to 20% of thapsigargin response genes including chaperones, components of ER-associated degradation, and apoptosis inhibitors. In addition, C/EBPδ supported the expression of the chemokines CXCL8 (IL-8) and CCL20, which are known for their tumor promoting and immunosuppressive properties. With a paradigm of short-term exposure to thapsigargin, which was sufficient to trigger prolonged activation of the UPR in cancer cells, we found that conditioned media from such cells induced cytokine expression in myeloid cells. In addition, activation of the CXCL8 receptor CXCR1 during thapsigargin exposure supported subsequent sphere formation by cancer cells. Taken together, these investigations elucidated a novel mechanism of ER stress-induced transmissible signals in tumor cells that may be particularly relevant in the context of pharmacological interventions.https://doi.org/10.1038/s41419-021-04318-y
spellingShingle Namratha Sheshadri
Dipak K. Poria
Shikha Sharan
Ying Hu
Chunhua Yan
Vishal N. Koparde
Kuppusamy Balamurugan
Esta Sterneck
PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells
Cell Death and Disease
title PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells
title_full PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells
title_fullStr PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells
title_full_unstemmed PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells
title_short PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells
title_sort perk signaling through c ebpδ contributes to er stress induced expression of immunomodulatory and tumor promoting chemokines by cancer cells
url https://doi.org/10.1038/s41419-021-04318-y
work_keys_str_mv AT namrathasheshadri perksignalingthroughcebpdcontributestoerstressinducedexpressionofimmunomodulatoryandtumorpromotingchemokinesbycancercells
AT dipakkporia perksignalingthroughcebpdcontributestoerstressinducedexpressionofimmunomodulatoryandtumorpromotingchemokinesbycancercells
AT shikhasharan perksignalingthroughcebpdcontributestoerstressinducedexpressionofimmunomodulatoryandtumorpromotingchemokinesbycancercells
AT yinghu perksignalingthroughcebpdcontributestoerstressinducedexpressionofimmunomodulatoryandtumorpromotingchemokinesbycancercells
AT chunhuayan perksignalingthroughcebpdcontributestoerstressinducedexpressionofimmunomodulatoryandtumorpromotingchemokinesbycancercells
AT vishalnkoparde perksignalingthroughcebpdcontributestoerstressinducedexpressionofimmunomodulatoryandtumorpromotingchemokinesbycancercells
AT kuppusamybalamurugan perksignalingthroughcebpdcontributestoerstressinducedexpressionofimmunomodulatoryandtumorpromotingchemokinesbycancercells
AT estasterneck perksignalingthroughcebpdcontributestoerstressinducedexpressionofimmunomodulatoryandtumorpromotingchemokinesbycancercells